Relmada Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US75955J4022
USD
3.60
-0.2 (-5.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryRelmada Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-5.26%
-0.51%
1W
-8.86%
-1.37%
1M
-17.62%
0.35%
YTD
-25.47%
0.54%
1Y
958.51%
13.99%
3Y
-12.62%
66.39%
5Y
-89.35%
77.77%
10Y
-89.35%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
29.96%
0%
29.96%
6 Months
485.37%
0%
485.37%
1 Year
958.51%
0%
958.51%
2 Years
-21.74%
0%
-21.74%
3 Years
-12.62%
0%
-12.62%
4 Years
-78.79%
0%
-78.79%
5 Years
-89.35%
0%
-89.35%

Relmada Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary